Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-02-24 to 2025-03-17
Current total value of award: $25819.02
Description: 4567419873!OCREVUS 300 MG/10 ML VIAL 10ML